NCT00312858View on ClinicalTrials.gov

Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)

PHASE4CompletedINTERVENTIONAL

Enrollment

653

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Hepatitis A Virus

Interventions

BIOLOGICAL

Comparator: VAQTA™ (Hepatitis A vaccine)

VAQTA™ 0.5 mL injection

BIOLOGICAL

Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine)

ProQuad™ 0.5 mL injection

BIOLOGICAL

Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)

Prevnar™ 0.5 mL injection

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00312858 - Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) | Biotech Hunter | Biotech Hunter